Keeping up with the science: Innovation in the health and care system post Brexit
Article
Innovation in health – new treatments, technologies and processes – can help drive improvements in healthcare and ultimately health outcomes. We are on the cusp of a new wave of innovation driven by robotics, big data and therapeutic breakthroughs such as cell and gene therapy.
However, the history of innovation in the UK shows that the health and care system is often slow to adopt new technologies. The government has tried to address the causes of this problem, most recently through the Accelerated Access Review (AAR) and Life Sciences (Industrial) Strategy.
Although these initiatives offer a number of sensible policy suggestions, the reality is that they will fail to deliver on their potential without a Brexit deal that prioritises health and care; a new long-term funding settlement for health and care; and a clear plan for system reform in the NHS.
Related items
Transformed by AI: How generative artificial intelligence could affect work in the UK – and how to manage it
Technological change is a good thing. It has brought exponential gains to living standards and is the foundation of modern society. Yet unmanaged technological change has always come with risks and disruptions.Celebrating 20 years of IPPR North
For two decades IPPR North has been at the centre of the debate about how to rebalance England's regions. Here we take stock of how far we have come and the role we have played in shaping the "levelling up" debate.Costing the Rwanda plan
Total payments to Rwanda for removing this cohort of people could range between £1.1 billion and £3.9 billion.